View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Tislelizumab 200 / Paclitaxel 175 / Cisplatin 80, Esophageal Cancer
Protocol-ID: 2622 V1.2 (Mini), TISL200/PACL175/CISP80, Esophageal CaIndication(s)
- Esophageal Cancer; ICD-10 C15.-
Squamous Cell Carcinoma
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 11.03.2026